LEP and metabolic syndrome: The metabolic syndrome and its components contribute to the persistence of chronic inflammation at a low level, and thus are associated with the presence of systemic markers of inflammation (including leptin, IL-6, TNF), which may contribute to the development of proliferative and inflammatory processes.